Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Compare to the Safety of Efavirenz and Nevirapine in Treating HIV Positive Patients With Mild Baseline Liver Function Test Impairment, and/or Hepatitis B or Hepatitis C Co-infection

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified December 2010 by Henan Provincial Hospital.
Recruitment status was:  Not yet recruiting
Sponsor:
Collaborator:
Merck Sharp & Dohme Corp.
Information provided by:
Henan Provincial Hospital
ClinicalTrials.gov Identifier:
NCT01273142
First received: January 6, 2011
Last updated: January 7, 2011
Last verified: December 2010
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is not yet open for participant recruitment.
  Estimated Study Completion Date: December 2012
  Estimated Primary Completion Date: October 2012 (Final data collection date for primary outcome measure)